Skip to main content
Skip to section navigation
Skip to footer
Home
About
Overview
Management Team
Board of Directors
Advisory Board
Pipeline
Overview
XRx-008 for Autosomal Dominant Polycystic Kidney Disease
XRx-101 for Coronavirus/COVID-19
XRX-225 for Type 2 Diabetic Nephropathy
Publications
Technology
News & Media
Press Releases
Events
In the News
Investors
Overview
News & Events
Presentations
Company Info
Financial Info
Stock Data
SEC Filings
SEDAR+
Governance
Contact
Presentations
Investors
Investors
Overview
News & Events
Overview
Press Releases
IR Calendar
Email Alerts
Presentations
Company Info
Overview
Management Team
Contacts
FAQ
Financial Info
Financial Results
Stock Data
Analyst Coverage
Quote
Charts
Historical Data
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
SEDAR+
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Board Diversity Matrix
Jun 24, 2024
Investor Presentation
rss_feed
RSS
Email Alerts
Contacts
RSS News Feed
